Preconditioning with low concentration NO attenuates subsequent NO-induced apoptosis in vascular smooth muscle cells via HO-1-dependent mitochondrial death pathway.

Nitric oxide (NO) signaling pathways are important in both the maintenance of vascular homeostasis and disease progression. Overproduction of NO has been associated with ischemia/reperfusion (I/R) injury. Growing evidences suggest that NO preconditioning has cytoprotective effects against I/R injury. However, the mechanism with which NO mediates these effects remains to be elucidated. The purpose of this study was to examine the mechanism of how NO preconditioning inhibits subsequent NO-induced apoptosis in vascular smooth muscle cells (VSMC), specifically focusing on heme oxygenase-1 (HO-1). According to our data, sodium nitroprusside (SNP) increased HO-1 expression in a concentration dependent manner. Preconditioning with low concentration SNP (0.3mM) inhibited subsequent high concentration SNP (1.5mM)-induced apoptosis, and this effect was reversed by the HO-1 inhibitor SnPP. Low concentration SNP-mediated protection involved p38 kinase inactivation and increased Bcl-2 expression. Furthermore, mitochondrial membrane potential was concomitantly increased with decreased expressions of Bax, Apaf-1, and activity of caspase-3, which was reversed by SnPP treatment. Our results show that low concentration SNP preconditioning suppresses subsequent high concentration SNP-induced apoptosis by inhibiting p38 kinase and mitochondrial death pathway via HO-1-dependent mechanisms in VSMC.

[1]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[2]  C. Patterson,et al.  Induction of Heme Oxygenase-1 Expression in Vascular Smooth Muscle Cells , 1997, The Journal of Biological Chemistry.

[3]  B. Brüne,et al.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. , 1996, The Biochemical journal.

[4]  U. Settmacher,et al.  Heme oxygenase-1 protects human hepatocytes in vitro against warm and cold hypoxia. , 2004, Journal of hepatology.

[5]  C. Thiemermann.  Inhaled CO: Deadly gas or novel therapeutic? , 2001, Nature Medicine.

[6]  A. Choi,et al.  Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[7]  A. M. Lefer,et al.  The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. , 1996, Cardiovascular research.

[8]  A. M. Lefer,et al.  Protection of Ischemia‐Reperfusion Injury by Sydnonimine NO Donors via Inhibition of Neutrophil‐Endothelium Interaction , 1993, Journal of cardiovascular pharmacology.

[9]  S. Paik,et al.  Synergistic cooperation between phorbol ester and IFN-gamma for induction of nitric oxide synthesis in murine peritoneal macrophages. , 1994, Journal of immunology.

[10]  P. Mcconnell,et al.  Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. , 1999, Circulation research.

[11]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[12]  S. Bae,et al.  The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death , 2005, Arthritis research & therapy.

[13]  A. Seifalian,et al.  Protection of the Liver by Ischemic Preconditioning: A Review of Mechanisms and Clinical Applications , 2003, Digestive Surgery.

[14]  Toru Takahashi,et al.  Protective role of heme oxygenase-1 in renal ischemia. , 2004, Antioxidants & redox signaling.

[15]  H. Lander,et al.  Differential Activation of Mitogen-activated Protein Kinases by Nitric Oxide-related Species* , 1996, The Journal of Biological Chemistry.

[16]  R. Munglani,et al.  An improved method for detection of apoptosis in tissue sections and cell culture, using the TUNEL technique combined with Hoechst stain. , 1998, Brain research. Brain research protocols.

[17]  S. Moncada,et al.  Inhibition of nitric oxide synthase as a potential therapeutic target. , 1999, Annual review of pharmacology and toxicology.

[18]  M. Maines,et al.  The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.

[19]  A. Choi,et al.  Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants1 , 2001, The Journal of Immunology.

[20]  W. Durante,et al.  Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. , 2002, Cardiovascular research.

[21]  W. Durante,et al.  Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. , 1997, Circulation research.

[22]  C. T. Wagner,et al.  Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. , 1997, The Journal of clinical investigation.

[23]  J. Ingwall,et al.  Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.

[24]  R. Foresti,et al.  Heme oxygenase-1 induction in skeletal muscle cells: hemin and sodium nitroprusside are regulators in vitro. , 1998, American journal of physiology. Cell physiology.

[25]  A. Edwards,et al.  Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation. , 1997, Journal of cell science.

[26]  J. Pernow,et al.  Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia-reperfusion in vivo. , 2002, Nitric oxide : biology and chemistry.

[27]  R. Ochs,et al.  Chondrocyte apoptosis induced by nitric oxide. , 1995, The American journal of pathology.

[28]  E. Nishio,et al.  Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. , 1996, Biochemical and biophysical research communications.

[29]  J. H. Lee,et al.  Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/A , 2004, European journal of pharmacology.

[30]  Hun-taeg Chung,et al.  Nitric oxide priming protects nitric oxide-mediated apoptosis via heme oxygenase-1 induction. , 2003, Free radical biology & medicine.

[31]  T. Ogihara,et al.  Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. , 1996, Hypertension.

[32]  S. Marklund,et al.  Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[33]  A. Choi,et al.  Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. , 1996, American journal of respiratory cell and molecular biology.

[34]  J M Land,et al.  Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases , 1997, Journal of neurochemistry.

[35]  P. Ferdinandy,et al.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia‐reperfusion injury and preconditioning , 2003, British journal of pharmacology.

[36]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[37]  M. Duchen,et al.  Mitochondria as Targets for Nitric Oxide-Induced Protection During Simulated Ischemia and Reoxygenation in Isolated Neonatal Cardiomyocytes , 2001, Circulation.

[38]  Christian Bogdan,et al.  Nitric oxide and the immune response , 2001, Nature Immunology.

[39]  A. M. Lefer,et al.  Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. , 1993, Circulation research.

[40]  P. Cannon,et al.  Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. , 1999, American journal of physiology. Heart and circulatory physiology.

[41]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  P. Kubes,et al.  Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. , 1994, Circulation research.

[43]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.

[44]  H. Drexler,et al.  Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. , 2004, Cardiovascular research.

[45]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[46]  R. Bolli.  Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. , 2001, Journal of molecular and cellular cardiology.

[47]  D. Sawyer,et al.  Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. , 1999, Circulation research.

[48]  M. Tohyama,et al.  Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide , 1998, Cell Death and Differentiation.

[49]  G. Dusting.  Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion and heart failure. , 1996, EXS.

[50]  M. Horiuchi,et al.  Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. , 1996, Circulation research.